Whether it’s in terms of logistics, geography, business or science, LégiaPark is ideally situated in the heart of a bustling and thriving region, positioned perfectly in the heart of the Euregion.
Liège is home to more than 140 Life Sciences companies, pioneers in the fields of oncology, cardiology, immunology, radiopharmacy and the development of innovative medical equipment. More than 350 million euros were raised in 2020 and the sector employs more than 4,000 people.
Liège is also a unique scientific and academic centre that includes a world-ranked university (ULiège), a teaching hospital (CHU) and a rich and varied healthcare landscape that is highly conducive to the development of life sciences.
Developed and managed by the Noshaq group, LégiaPark is designed to be a unifying project that supports the economic development of life sciences in the province of Liège. Operating from LégiaPark means being part of a caring environment that offers appropriate support in business creation and development, based along four main lines:
- Business support
- Expertise & Technology
Setting up business in LégiaPark means joining numerous other companies at the cutting edge of the ecosystem:
Op2Lysis mandate is to improve the management and treatment of cerebrovascular thrombotic diseases by offering a breakthrough technology accessible to any hospital in order to reduce patient dependency and associated costs. Its DNA is to base development choices on existing and documented clinical proof of concept.
ExeVir is a clinical-stage company developing novel antibody therapies that help patients ward off infectious diseases. Their focus is on protecting populations unable to benefit from vaccines, such as immunocompromised individuals. The versatile VHH platform enables both prevention and treatment of bacterial and viral threats.
Valentiny Architects is an office specialised in the field of architecture and interior design.
Bureau Greisch is an engineering and architectural firm. They undertake design and construction supervision missions for infrastructure. In the case of buildings, Bureau Greisch work on missions right through from programme development to commissioning, including architecture, energy design, stability studies and building services engineering.
MOURY CONSTRUCT is a family group with a hundred years of experience, specialising in renovation, residential and non-residential construction for the private and public markets.
WUST is a general construction company. With a presence in Wallonia, Brussels and the Grand Duchy of Luxembourg, WUST builds residential complexes, office buildings, industrial halls and commercial areas, buildings for education, health care and personal assistance, sports and leisure facilities, renovation and restoration work, as well as service work for industries.
The CHC Health Group brings together clinics, medical centres, homes for the elderly, a care facility for the disabled, a crèche and operational services in Liege, Belgium. The CHC Health Group is a key player in the healthcare landscape of the province of Liege. Most of our patients and residents come from the outskirts of Liège, but increasingly, thanks to the diversity of our services and partnerships, we are also catering for patients from further afield.
Fédérale Assurance is a mutual insurer with a cooperative purpose.
Public Regulated Real Estate Company
TELEMEDICINE TECHNOLOGIES BELGIUM
Telemedicine Technologies is a publisher of collaborative e-Health solutions, leader in the field of Clinical Research with its CleanWEB solution, a secure internet platform dedicated to the electronic management of clinical studies and registries. Telemedicine Technologies is also an actor involved in the evaluation of patient monitoring at home, with connected objects.
PlusOne is the first recruitment office entirely dedicated to SMEs active in the field of science or technology in Belgium.
PDC LINE PHARMA
PDC*line Pharma is a French-Belgian clinical-stage biotechnology company developing a new class of innovative cancer immunotherapies.
CoCEPTIO aims to be the business and technical expertise centre that offers more integrated and pragmatic “tailor-made” project approaches. Their mission is to define, design and implement multi-technical installations with a commitment to results to enable its customers to focus on their process and their business.
B2C Engineering is a company active in the industrial sector. Their competences cover the entire industrial production chain and they are specialised in the integration of automation, industrial IT, CSI, IoT, MES implementation, energy accounting and robotics solutions.
WALLONIE SANTÉ is the Walloon investment fund dedicated to financing providers in Social Action and Health.
Radiomics conducts a new-generation research and imaging organisation, based in Liège, built on the unparalleled experience of its founders, who are pioneers in radiomics.
Noshaq is an investment fund and project developer, with a portfolio of 474 companies. Noshaq is the lead funding partner for the creation and development of SMEs in the region of Liège, with a strong presence alongside businesses operating in life sciences.
Nomics designs and sells medical equipment and specialises in the improvement of diagnostics and treatment using a minimum quantity of invasive sensors and automatic analysis.
Hyloris is a biopharma company that focuses on innovation and the reinvention and optimisation of existing treatments to meet major healthcare needs, as well as bringing relevant enhancements to patients, health professionals and payers.
Gevers is a leading company in the protection of intellectual property, specialising in patents, for which it offers various associated services in a way which guarantees that every client is able to benefit from the company’s wide-ranging expertise in this field.
Gabi SmartCare enables health professionals, researchers and families to better diagnose children through the smart collection and processing of specific data.
EXO Biologics is a Belgian biotech company specialising in research into extracellular vesicles, exosomes and the development of drugs.